Fenugreek and Testosterone: What the Research Actually Shows

Slightly, on one measure only. A meta-analysis of 7 trials and 449 participants finds a significant but small effect on total testosterone, with a standardized mean difference of 0.32 and a confidence interval of 0.09 to 0.55. On free testosterone, lean mass, fat mass, and leg press, the intervals all cross zero: these effects are not statistically significant.

The data do not permit conclusions about it: the measured effect is 0.24 but with a confidence interval ranging from -0.04 to 0.52, which crosses zero just barely. This is an important point physiologically, since the free fraction is the one that is biologically available. An increase in total testosterone without a demonstrated increase in the free fraction has uncertain significance.

This is where individual trials are most straightforward. A double-blind trial in 49 trained men over 8 weeks of supervised resistance training reports a leg press gain of 84.6 kg versus 48 kg under placebo (p < 0.001), a bench press gain of 9.1 kg versus 4.3 kg (p = 0.01), and a fat mass reduction of 2.3 percentage points versus 0.39 (p < 0.001). However, the meta-analysis aggregating all trials yields a more modest pooled effect, at the threshold of significance.

No, and this selectivity is rather reassuring. In available trials, effects focus on maximal strength and body composition, while anaerobic power measured by the Wingate test and muscular endurance show no difference between groups. A product that improved everything indiscriminately would be more suspect than a product with a coherent effect profile.

This is the most directly actionable angle of the evidence. One trial in 47 trained men compared 5 g of creatine with 70 g of dextrose against 3.5 g of creatine with 900 mg of fenugreek extract, without dextrose, over 8 weeks. Both protocols produced comparable gains in bench press strength and body composition. The authors conclude that this combination could enhance creatine uptake while eliminating the need for excessive amounts of simple carbohydrates.

No. The meta-analysis included 71 women out of 449 participants, and its authors explicitly state that no conclusions can be drawn for female athletes. The results presented here therefore concern men.

This is the most useful distinction in this evidence. In the most recent trial, plasma testosterone increased by 13% from baseline, an impressive and precise figure. But the placebo group also improved, and the gap between the two did not reach significance. Hormone concentrations vary with season, sleep, weight, and the simple fact of participating in a study. Only comparison versus placebo allows firm conclusions.

In 95 men aged 40 to 80 over 12 weeks, with four compared doses from 0 to 1800 mg per day: total plasma testosterone and free testosterone index increased significantly from baseline, but not significantly versus placebo. Salivary testosterone, however, beat placebo. At 1800 mg, the free testosterone index improved by 12.2% and salivary testosterone by 19.6%.

The trial authors suggest that saliva might be preferable for assessing the free fraction, as it contains no protein-bound testosterone. Indeed, it was on this measure that the result versus placebo was significant, whereas it was not on plasma. This divergence between two measures of the same parameter well illustrates the fragility of the signal.

No, and this is an important point. In the dose-response trial, no subjective effects were observed, neither benefits nor adverse effects. A measurable biological variation in the laboratory is not necessarily a perceptible variation in daily life. This is a nuance that commercial communications systematically omit.

This is the most striking counter-example of the evidence. The same lead researcher, with the same dose of 600 mg per day and the same 12-week duration, found hormonal increase in aging men, and no hormonal change in men with benign prostatic hyperplasia. The effect thus probably depends on the population, the baseline hormonal profile, and the extract used. This also explains why a meta-analysis yields a more cautious pooled effect than the most favorable trials taken individually.

This is the most favorable trial of the evidence. In 120 men aged 43 to 70 receiving 600 mg per day of standardized extract for 12 weeks, it reports a significant reduction in male aging symptom score, improved sexual function including morning erections and frequency of sexual activity, and increased total and free testosterone versus placebo. Two clarifications: it concerns a specific patented extract, and one of the authors declares a commercial affiliation in the sector.

These are the highest figures of the evidence: in 50 men aged 35 to 65 receiving 500 mg per day of an extract enriched to 20% protodioscin for 12 weeks, free testosterone was improved up to 46% in 90% of participants, and sperm count in 85.4%. Essential point to know: the protocol was single-arm and open-label, without placebo group or blinding, and the authors are affiliated with the center that developed this extract. This is an encouraging exploratory study, not a demonstration.

One trial suggests so: the one on Testofen extract in aging men, which reports improved sexual function including morning erections and frequency of sexual activity. The more recent dose-response trial, however, observed no subjective effects reported by participants. A signal therefore exists, on a single trial, with a specific extract. Persistent decreased libido warrants medical evaluation.

These are not interchangeable products. All cited trials test standardized extracts, often patented, at doses of 500 to 1800 mg per day. An extract is a concentrated fraction titrated on certain compounds; a powder is the whole seed ground with its fiber. Nothing permits affirming that results obtained on one apply to the other, and we do not do so for our own product.

The presented trials reported no notable adverse effects. The trial in men with benign prostatic hyperplasia provides a useful element: after 12 weeks, prostate-specific antigen and safety markers remained unchanged and within normal limits. Nevertheless, precautions exist, particularly during pregnancy and with antidiabetic or anticoagulant treatment: these are detailed in our general fenugreek guide.

With a consultation and a blood test. Fatigue, decreased libido, and erectile dysfunction have identifiable medical causes, some of them serious, and an evaluation guides everything else. Next comes sleep, closely linked to hormone production, then body composition and physical activity, then micronutrient status verified by testing. Plants come in fifth place.

No, and it should not delay appropriate medical care. A confirmed androgenic deficit is a medical diagnosis that requires specialized follow-up, with therapeutic options far beyond what a supplement can offer. If your symptoms are concerning you, a blood test is the first useful step.

That several randomized, double-blind trials report, against placebo, gains in maximum strength, a decrease in fat mass, and increases in total and bioavailable testosterone, with sometimes significant differences. That the meta-analysis aggregating all studies shows a more modest effect, significant for total testosterone and borderline for other outcomes, as not all trials converge. That combining it with creatine allows for a reduced creatine dose and the elimination of dextrose. And that all these results are based on standardized extracts at 500 to 1800 mg per day.